Generated by AI
Cryoport Inc. is a global life sciences logistics and services company focused on temperature-controlled supply chain solutions for biologic materials. Cryoport Inc. supports the movement, storage, handling, and monitoring of sensitive products used in cell and gene therapy, biopharmaceuticals, animal health, and reproductive medicine. Its current offerings include specialized bio-logistics, bio-storage, bio-processing, cryopreservation, and cryogenic equipment, along with related software and monitoring tools designed to help maintain product integrity throughout transit and storage. Through its Life Sciences Services and Life Sciences Products segments, Cryoport Inc. serves biotechnology and pharmaceutical companies, contract research organizations, fertility clinics, and other healthcare-focused customers worldwide. Headquartered in Brentwood, Tennessee, Cryoport Inc. plays an important role in the infrastructure that supports advanced therapies and other temperature-sensitive life sciences applications.
Website112 Westwood Place
Brentwood, TN, 37027
United States
The latest articles about CYRX.
Cryoport reported third quarter 2026 revenue of US$50.22 million compared to US$44.23 million a year earlier, with a wider net loss of US$10.85 million and basic loss per share of US$0.25. The business lifted full year 2026 revenue guidance to a range of US$197 million to US$199 million, highlighting confidence in demand for its services despite ongoing losses. We will now examine how Cryoport's raised 2026 revenue guidance could reshape the existing investment narrative around its growth...
Summary of May 8's posts. Generated by AI.
Summary of Aug 6's posts. Generated by AI.
Cryoport (CYRX) has become a talking point after its third quarter 2026 report, which paired higher revenue with a wider loss and an increase in full year sales guidance to US$197 million to US$199 million. The guidance hike has landed in a market that was already re-rating Cryoport, with the share price at US$20.47 after a 7.17% 1-day move and a 114.12% year-to-date share price return. The 1-year total shareholder return of 139.70% points to strong recent momentum despite a 5-year total...
Summary of Aug 6's posts. Generated by AI.
Investors talking about CYRX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.